News and Trends 16 Dec 2022 Sosei Heptares and Lilly enter agreement on diabetes and metabolic diseases …in these important areas of unmet need.” Ruth Gimeno, group vice president, diabetes and metabolic research, Lilly said: “Continued innovation across diabetes and metabolic diseases has been a key priority… December 16, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2020 First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M …part of the money to fund the development of small molecule treatments for rare diseases, including its lead candidate aimed to treat lysosomal storage disorders. The rest of the money… February 10, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
2024 biotech deals tracker: the latest partnerships and M&A …HAYA Therapeutics, based in Switzerland, has partnered with Lilly, based in the United States, to discover genome targets for metabolic diseases. HAYA is set to receive up to $1 billion… March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Sep 2025 10 biotech companies in China you should know about …metabolic diseases, neurology, and infectious diseases Recent news: Announced that a phase 3 study of its anti-IL-17A monoclonal antibody candidate met its primary endpoints Junshi Biosciences is developing an array… September 16, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Apr 2025 13 anti-aging startups on a mission to extend lives …Received $4 million in funding San Diego-based anti-aging biotech company Rejuvenate Bio is developing novel gene therapies for chronic age-related diseases, with a particular focus on cardiac and metabolic diseases…. April 8, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 3 Dec 2025 Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 …to treat autoimmune diseases has become extremely popular in recent years, as B cells contribute to certain autoimmune diseases by producing autoantibodies that mistakenly attack the body’s own tissues. CUE-501… December 3, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Nov 2025 Beyond GLP-1s: is there a new wave of metabolic disease treatments? The likes of Ozempic and Mounjaro stirred a media frenzy over two years ago, which has stuck around, as off-label GLP1 agonists have taken over online market spaces. But many people who have metabolic diseases like diabetes and… November 26, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2024 Fourteen biotech companies with market caps exceeding $100 billion …conditions including immune diseases, cancer, neurological disorders, infectious diseases, cardiovascular, and metabolic diseases. Its consumer products span oral care, baby care, beauty, over-the-counter medicines, women’s health, and wound care categories…. March 5, 2024 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2022 NTU Singapore opens microbiome research center to study obesity and chronic diseases …microbes causes the body to be more susceptible to disorders such as obesity, metabolic diseases, cancers, lung, and skin diseases. The new research centre is led by programme director, Sunny… September 14, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2018 Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases? …candidate, MIN-102, for X-linked Adrenoleukodystrophy, spun out Gain Therapeutics last week. This new biotech will use a platform called SEE-Tx to develop pharmacological chaperones for rare metabolic diseases. These small… February 28, 2018 - 8 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Mar 2025 12 AI drug discovery companies you should know about …diseases Recent funding: Raised $400 million in series C round Recent news: Formed collaboration with Eli Lilly to advance novel treatments for metabolic diseases, including MASLD By generating high-throughput, functional… March 27, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Dec 2024 10 biotech companies to watch in 2025 …obesity and metabolic diseases. Going against the grain, the company believes that, despite their success, currently approved GLP-1 agonist therapies still have a number of flaws that suggest they do… December 16, 2024 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email